Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler

Study Title

A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing

Teva Identifier

ABS-AS-306

ClinicalTrials.gov Identifier

NCT01218009

Study Status

Terminated

Trial Condition(s)

Asthma

Interventions

Drug: Placebo Spiromax | Drug: Albuterol Spiromax

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

10/01/2010 - 12/01/2010

Phase

Phase 3

Study Type

Interventional